As an early stage VC, you miss some big ones. The author explores two big early stage biotech deals he missed, Agios and Juno, with some reflections on how they went down.
from Forbes Real Time https://www.forbes.com/sites/brucebooth/2018/03/23/two-really-big-fish-that-got-away/
via IFTTT
No comments:
Post a Comment